Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-12 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-13 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-11 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-14 |
mRNA | DCHS1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-13 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |